These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16852343)

  • 41. Secondary structure conversions of Alzheimer's Abeta(1-40) peptide induced by membrane-mimicking detergents.
    Wahlström A; Hugonin L; Perálvarez-Marín A; Jarvet J; Gräslund A
    FEBS J; 2008 Oct; 275(20):5117-28. PubMed ID: 18786140
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Controlling amyloid growth in multiple dimensions.
    Dong J; Lu K; Lakdawala A; Mehta AK; Lynn DG
    Amyloid; 2006 Dec; 13(4):206-15. PubMed ID: 17107881
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aggregation of liposomes induced by the toxic peptides Alzheimer's Abetas, human amylin and prion (106-126): facilitation by membrane-bound GM1 ganglioside.
    Kurganov B; Doh M; Arispe N
    Peptides; 2004 Feb; 25(2):217-32. PubMed ID: 15063003
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dissociation of Abeta(16-22) amyloid fibrils probed by molecular dynamics.
    Takeda T; Klimov DK
    J Mol Biol; 2007 May; 368(4):1202-13. PubMed ID: 17382346
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Abeta-globulomers are formed independently of the fibril pathway.
    Gellermann GP; Byrnes H; Striebinger A; Ullrich K; Mueller R; Hillen H; Barghorn S
    Neurobiol Dis; 2008 May; 30(2):212-20. PubMed ID: 18353662
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pyroglutamate formation influences solubility and amyloidogenicity of amyloid peptides.
    Schlenzig D; Manhart S; Cinar Y; Kleinschmidt M; Hause G; Willbold D; Funke SA; Schilling S; Demuth HU
    Biochemistry; 2009 Jul; 48(29):7072-8. PubMed ID: 19518051
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The anti-amyloidogenic effect is exerted against Alzheimer's beta-amyloid fibrils in vitro by preferential and reversible binding of flavonoids to the amyloid fibril structure.
    Hirohata M; Hasegawa K; Tsutsumi-Yasuhara S; Ohhashi Y; Ookoshi T; Ono K; Yamada M; Naiki H
    Biochemistry; 2007 Feb; 46(7):1888-99. PubMed ID: 17253770
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Monitoring the earliest amyloid-beta oligomers via quantized photobleaching of dye-labeled peptides.
    Dukes KD; Rodenberg CF; Lammi RK
    Anal Biochem; 2008 Nov; 382(1):29-34. PubMed ID: 18694719
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Kinetics of inhibition of beta-amyloid aggregation by transthyretin.
    Liu L; Murphy RM
    Biochemistry; 2006 Dec; 45(51):15702-9. PubMed ID: 17176092
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phage display affords peptides that modulate beta-amyloid aggregation.
    Orner BP; Liu L; Murphy RM; Kiessling LL
    J Am Chem Soc; 2006 Sep; 128(36):11882-9. PubMed ID: 16953628
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The inflammation-sensitive protein alpha 1-anti-chymotrypsin neutralizes fibrillar aggregation and cytotoxicity of the beta-amyloid peptide more effectively than alpha 1-antitrypsin.
    Giunta S; Galeazzi R; Marcellini M; Corder EH; Galeazzi L
    Clin Biochem; 2007 Aug; 40(12):887-92. PubMed ID: 17512513
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Templating effect of lipid membranes on Alzheimer's amyloid beta peptide.
    Ege C; Majewski J; Wu G; Kjaer K; Lee KY
    Chemphyschem; 2005 Feb; 6(2):226-9. PubMed ID: 15751341
    [No Abstract]   [Full Text] [Related]  

  • 53. Conformation and topology of amyloid beta-protein adsorbed on a tethered artificial membrane probed by surface plasmon field-enhanced fluorescence spectroscopy.
    Song H; Ritz S; Knoll W; Sinner EK
    J Struct Biol; 2009 Oct; 168(1):117-24. PubMed ID: 19576283
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lipids enhance apolipoprotein C-II-derived amyloidogenic peptide oligomerization but inhibit fibril formation.
    Hung A; Griffin MD; Howlett GJ; Yarovsky I
    J Phys Chem B; 2009 Jul; 113(28):9447-53. PubMed ID: 19537801
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new amyloid-like beta-aggregate with amyloid characteristics, except fibril morphology.
    Chang ES; Liao TY; Lim TS; Fann W; Chen RP
    J Mol Biol; 2009 Jan; 385(4):1257-65. PubMed ID: 19041877
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cross-strand pairing and amyloid assembly.
    Liang Y; Pingali SV; Jogalekar AS; Snyder JP; Thiyagarajan P; Lynn DG
    Biochemistry; 2008 Sep; 47(38):10018-26. PubMed ID: 18759497
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fibril aggregation inhibitory activity of the beta-sheet breaker peptides: a molecular docking approach.
    Chini MG; Scrima M; D'Ursi AM; Bifulco G
    J Pept Sci; 2009 Mar; 15(3):229-34. PubMed ID: 19090016
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Potential lead for an Alzheimer drug: a peptide that blocks intermolecular interaction and amyloid beta protein-induced cytotoxicity.
    Kwak JW; Kim HK; Chae CB
    J Med Chem; 2006 Aug; 49(16):4813-7. PubMed ID: 16884292
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunogenic, antigenic, fibrillogenic and inflammatory properties of new simplified beta-amyloid peptides.
    Rossi M; Piovesan P; Ghirardi O; Mastroianni D; Bombardi V; Battistini L; Cencioni MT; Capobianco D; Borsini F; Colombo M; Verdoliva A
    Mol Immunol; 2009 Aug; 46(13):2524-32. PubMed ID: 19535144
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanism of formation of amyloid protofibrils of barstar from soluble oligomers: evidence for multiple steps and lateral association coupled to conformational conversion.
    Kumar S; Mohanty SK; Udgaonkar JB
    J Mol Biol; 2007 Apr; 367(4):1186-204. PubMed ID: 17292913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.